We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$407M
AUM Growth
+$25.4M
Cap. Flow
-$3.44M
Cap. Flow %
-0.84%
Top 10 Hldgs %
41.6%
Holding
76
New
4
Increased
14
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.83M
2
VMC icon
Vulcan Materials
VMC
+$1.8M
3
T icon
AT&T
T
+$1.21M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$466K
5
CVX icon
Chevron
CVX
+$290K

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$3.12M
2
AGN
Allergan plc
AGN
+$2.36M
3
RTN
Raytheon Company
RTN
+$965K
4
VAR
Varian Medical Systems, Inc.
VAR
+$714K
5
MRK icon
Merck
MRK
+$670K

Sector Composition

Rank Sector Weight
1 Healthcare 23.56%
2 Technology 21.67%
3 Industrials 15.11%
4 Materials 8.79%
5 Financials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$29M 7.13%
686,564
-14,104
-2% -$589K
INTC icon
2
Intel
INTC
$473B
$21.6M 5.3%
467,204
-8,445
-2% -$369K
RTN
3
DELISTED
Raytheon Company
RTN
$19.6M 4.83%
104,586
-5,175
-5% -$965K
ECL icon
4
Ecolab
ECL
$80.4B
$17M 4.17%
126,589
-925
-0.7% -$123K
COP icon
5
ConocoPhillips
COP
$157B
$15.2M 3.74%
277,483
-892
-0.3% -$45.9K
SYK icon
6
Stryker
SYK
$127B
$14.8M 3.63%
95,554
-485
-0.5% -$74K
VAR
7
DELISTED
Varian Medical Systems, Inc.
VAR
$14M 3.44%
125,849
-6,640
-5% -$714K
JPM icon
8
JPMorgan Chase
JPM
$951B
$13.8M 3.38%
128,666
+320
+0.2% +$32.4K
MRK icon
9
Merck
MRK
$366B
$13M 3.18%
241,417
-12,094
-5% -$670K
PAYX icon
10
Paychex
PAYX
$45.2B
$11.4M 2.79%
167,068
-1,525
-0.9% -$100K
CSCO icon
11
Cisco
CSCO
$433B
$11.2M 2.75%
292,676
+4,210
+1% +$150K
VMC icon
12
Vulcan Materials
VMC
$35.6B
$11.1M 2.73%
86,470
+14,715
+21% +$1.8M
JNJ icon
13
Johnson & Johnson
JNJ
$646B
$10.9M 2.67%
77,928
+80
+0.1% +$11.1K
BA icon
14
Boeing
BA
$166B
$10.9M 2.67%
36,907
-1,605
-4% -$434K
CPRT icon
15
Copart
CPRT
$30.5B
$10.5M 2.57%
969,560
-33,400
-3% -$325K
ABBV icon
16
AbbVie
ABBV
$451B
$10.4M 2.55%
107,409
-2,610
-2% -$246K
HOLX
17
DELISTED
Hologic
HOLX
$9.14M 2.25%
213,816
+3,015
+1% +$120K
LKQ icon
18
LKQ Corp
LKQ
$6.46B
$7.52M 1.85%
184,815
-1,800
-1% -$68.9K
MSFT icon
19
Microsoft
MSFT
$3.81T
$7.47M 1.84%
87,377
-1,900
-2% -$156K
WWD icon
20
Woodward
WWD
$20.2B
$7.2M 1.77%
94,054
-1,980
-2% -$155K
GNTX icon
21
Gentex
GNTX
$4.78B
$7.08M 1.74%
338,060
-9,105
-3% -$181K
TFC icon
22
Truist Financial
TFC
$61.6B
$7.07M 1.74%
142,109
-2,645
-2% -$128K
NTNX icon
23
Nutanix
NTNX
$18.7B
$6.41M 1.57%
181,710
+8,580
+5% +$260K
RMD icon
24
ResMed
RMD
$34.7B
$5.94M 1.46%
70,095
+845
+1% +$69.8K
PEP icon
25
PepsiCo
PEP
$193B
$5.83M 1.43%
48,586
-1,325
-3% -$151K
1
2 3

Similar funds

WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $842M AUM 28.01% 1-Year Est. Return
EBSAM
Eubel Brady & Suttman Asset Management Miamisburg, Ohio $842M AUM 17.25% 1-Year Est. Return
KM
Kora Management Brooklyn, New York $843M AUM 11.3% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $843M AUM 39.5% 1-Year Est. Return
PMWMG
Parr McKnight Wealth Management Group Minneapolis, Minnesota $844M AUM 18.11% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $844M AUM 16.51% 1-Year Est. Return
LWA
Lineweaver Wealth Advisors Valley View, Ohio $845M AUM 20.71% 1-Year Est. Return
FPF
First Pacific Financial Vancouver, Washington $839M AUM 19.87% 1-Year Est. Return

LaFleur & Godfrey's Q4 2017 Portfolio in Review

As of Q4 2017, LaFleur & Godfrey held 76 positions worth $407M, up 6.7% from $382M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

LaFleur & Godfrey's Q4 2017 filing shows 4 new, 14 increased, 36 reduced and 2 closed positions. Its largest new stake was Gilead Sciences: 63,632 shares worth $4.56M. The largest sale was Perrigo, an estimated $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • LaFleur & Godfrey's largest Q4 2017 buy was Gilead Sciences: 63,632 shares worth $4.56M.
  • LaFleur & Godfrey added most to Vulcan Materials in Q4 2017, an estimated $1.8M increase.
  • LaFleur & Godfrey's biggest Q4 2017 reduction was Perrigo, cutting an estimated $3.12M.
  • LaFleur & Godfrey fully exited ProShares Short S&P500 in Q4 2017, selling an estimated $222K.
  • LaFleur & Godfrey's ten largest holdings make up 42% of its $407M portfolio in Q4 2017.
  • LaFleur & Godfrey opened 4 new positions and closed 2 in Q4 2017.
  • LaFleur & Godfrey's portfolio value rose 6.7% quarter-over-quarter to $407M.

Based on LaFleur & Godfrey's 13F filing for Q4 2017, filed 22 Jan 2018.